enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. HIV vaccine development - Wikipedia

   en.wikipedia.org/wiki/HIV_vaccine_development

   An HIV vaccine is a potential vaccine that could be either a preventive vaccine or a therapeutic vaccine, which means it would either protect individuals from being infected with HIV or treat HIV-infected individuals. It is thought that an HIV vaccine could either induce an immune response against HIV (active vaccination approach) or consist of ...

3. Gilead Unveils New Yearly HIV Injection To Offer Hope for ...

   www.aol.com/gilead-unveils-yearly-hiv-injection...

   At the HIV Analyst & Investor Event on Tuesday, Gilead Sciences Inc. (NASDAQ:GILD) revealed that it is developing a once-yearly injectable formulation for lenacapavir. The annual formulation is ...

4. A 'miracle' HIV shot, surprising shingles vaccine benefit and ...

   www.aol.com/lifestyle/miracle-hiv-shot...

   A new HIV drug is very promising. A twice-yearly shot from pharmaceutical company Gilead was 100% effective in preventing HIV infections in women, per new research. The study, which involved 5,338 ...

5. SAV001 - Wikipedia

   en.wikipedia.org/wiki/SAV001

   Various approaches for HIV vaccine development. The SAV001-H vaccine is considered to be the first whole killed genetically modified HIV-1 vaccine.. According to Dr. Kang, the HIV-1 strain was genetically engineered such that first, “the gene responsible for pathogenicity, known as nef” is removed to make it non-pathogenic.

6. Lenacapavir injection lowers HIV risk by 96% - AOL

   www.aol.com/lenacapavir-injection-lowers-hiv...

   The current study was funded by Gilead Sciences, which produce lenacapavir. Twice-yearly lenacapavir could act like an HIV vaccine. This research presents an effective option for preventing HIV ...

7. International AIDS Vaccine Initiative - Wikipedia

   en.wikipedia.org/wiki/International_AIDS_Vaccine...

   The International AIDS Vaccine Initiative (IAVI) is a global not-for-profit, public-private partnership working to accelerate the development of vaccines to prevent HIV infection and AIDS. IAVI researches and develops vaccine candidates, conducts policy analyses , serves as an advocate for the HIV prevention field and engages communities in the ...

8. New HIV prevention drug could reach poorest countries ... - AOL

   www.aol.com/news/hiv-prevention-drug-could-reach...

   A new long-acting preventive HIV drug could reach the world’s poorest countries by the end of 2025 or early 2026, a global health official told Reuters on Tuesday. The ambition is to start ...

9. AIDSVAX - Wikipedia

   en.wikipedia.org/wiki/AIDSVAX

   AIDSVAX is an experimental HIV vaccine that was developed originally at Genentech in San Francisco, California, and later tested by the VaxGen company, a Genentech offshoot. [1] The development and trials of the vaccine received significant coverage in the international media, but American trials proved inconclusive.